ArticlePloS one2016

Preclinical Evidence of Anti-Tumor Activity Induced by EZH2 Inhibition in Human Models of Synovial Sarcoma.

Satoshi Kawano et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.